Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (11-20 of 208) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|September 13, 2016
Is it time to extend criteria for hepatic resection in the treatment of hepatocellular carcinoma?Franco Trevisani, Laura Bucci, Francesca Garuti, et al.
Biomedicines|May 16, 2023
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or ResistanceFilippo Pelizzaro, Fabio Farinati, Franco Trevisani
Lancet (London, England)|February 13, 2007
Alcohol misuse and traffic accidentsFabio Caputo, Franco Trevisani, Mauro Bernardi
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2016
Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levelsAlessandro Cucchetti, Rita Golfieri, Franco Trevisani, et al.
Recenti Progressi in Medicina|February 17, 2018
[Personalized healthcare in hepatocellular carcinoma. Multi-society Italian position paper.]Franco Trevisani, Francesca Garuti, Andrea Neri
Seminars in Liver Disease|March 9, 2019
Alpha-fetoprotein for Diagnosis, Prognosis, and Transplant SelectionFranco Trevisani, Francesca Garuti, Andrea Neri
Liver Cancer|August 8, 2024
Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic ReviewLorenzo Lani, Benedetta Stefanini, Franco Trevisani
Vaccines|October 7, 2020
Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?Francesco Tovoli, Stefania De Lorenzo, Franco Trevisani
Cancers|October 14, 2022
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular CarcinomaStefania De Lorenzo, Francesco Tovoli, Franco Trevisani
Hepatology (Baltimore, Md.)|June 29, 2011
Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the deadEdoardo G Giannini, Fabio Farinati, Franco Trevisani
Pageof 21

Showing results (11-20 of 208) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|September 13, 2016
Is it time to extend criteria for hepatic resection in the treatment of hepatocellular carcinoma?Franco Trevisani, Laura Bucci, Francesca Garuti, et al.
Biomedicines|May 16, 2023
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or ResistanceFilippo Pelizzaro, Fabio Farinati, Franco Trevisani
Lancet (London, England)|February 13, 2007
Alcohol misuse and traffic accidentsFabio Caputo, Franco Trevisani, Mauro Bernardi
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2016
Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levelsAlessandro Cucchetti, Rita Golfieri, Franco Trevisani, et al.
Recenti Progressi in Medicina|February 17, 2018
[Personalized healthcare in hepatocellular carcinoma. Multi-society Italian position paper.]Franco Trevisani, Francesca Garuti, Andrea Neri
Seminars in Liver Disease|March 9, 2019
Alpha-fetoprotein for Diagnosis, Prognosis, and Transplant SelectionFranco Trevisani, Francesca Garuti, Andrea Neri
Liver Cancer|August 8, 2024
Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic ReviewLorenzo Lani, Benedetta Stefanini, Franco Trevisani
Vaccines|October 7, 2020
Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?Francesco Tovoli, Stefania De Lorenzo, Franco Trevisani
Cancers|October 14, 2022
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular CarcinomaStefania De Lorenzo, Francesco Tovoli, Franco Trevisani
Hepatology (Baltimore, Md.)|June 29, 2011
Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the deadEdoardo G Giannini, Fabio Farinati, Franco Trevisani
Pageof 21